WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, a leading provider of AI-driven molecular and immune profiling solutions today announced that an abstract has been accepted as a poster presentation for the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo, which will be held November 14 – 18, 2023, at the Salt Palace…
Click here to view original post
News
Civica nabs trial partner as it forges ahead to create more affordable insulins
A nonprofit drug manufacturer is moving forward with plans to stem the rising tide of insulin costs in the US. Utah-based Civica has selected German-based research organization Profil as its human clinical trial partner to […]
News
The Future of Intoxication Detection May Be in Your Voice
AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) — BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement and workplace safety to […]
News
WB Blends and Yellow Emperor Announce Strategic Partnership
SPANISH FORK, Utah, Aug. 12, 2026 /PRNewswire/ — WB Blends, a fast-growing dietary supplement manufacturer, today announced a strategic partnership with Yellow Emperor, a custom liquid dietary supplement manufacturer based in Eugene, Oregon. The collaboration […]
